BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 19103857)

  • 41. [Hemoglobinpathy S--clinical manifestations in children in a Zairian family].
    Curcić B; Popović M; Cahurska T; Beksedić D
    Bilt Hematol Transfuz; 1977; 5(3-4):81-7. PubMed ID: 615614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Targeted newborn screening for sickle-cell anemia: Sickling test (Emmel test) boundaries in the prenatal assessment in West African area].
    Diallo DA; Guindo A; Touré BA; Sarro YS; Sima M; Tessougué O; Baraika MA; Guindo P; Traoré M; Diallo M; Dorie A
    Rev Epidemiol Sante Publique; 2018 May; 66(3):181-185. PubMed ID: 29625861
    [TBL] [Abstract][Full Text] [Related]  

  • 43. One-third of the new paediatric patients with sickle cell disease in The Netherlands are immigrants and do not benefit from neonatal screening.
    Peters M; Fijnvandraat K; van den Tweel XW; Garre FG; Giordano PC; van Wouwe JP; Pereira RR; Verkerk PH
    Arch Dis Child; 2010 Oct; 95(10):822-5. PubMed ID: 20576657
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Sickle cell anemia in children in Zaire (Congo-Kinshassa)].
    Leszczyńska-Moll J
    Pol Tyg Lek; 1974 Nov; 29(46):1991-4. PubMed ID: 4431748
    [No Abstract]   [Full Text] [Related]  

  • 45. [Purulent meningitis in children with sickle cell anemia. Report of 47 cases].
    Omanga U; Tady M; Ntihinyurwa M; Badibanga ; Disengomoka I
    Ann Pediatr (Paris); 1976 Nov; 23(11):741-5. PubMed ID: 16106884
    [No Abstract]   [Full Text] [Related]  

  • 46. [Neonatal screening for sickle cell anemia and other hemoglobinopathies in Martinique].
    Brunod M
    Med Trop (Mars); 1999; 59(4):412. PubMed ID: 10816758
    [No Abstract]   [Full Text] [Related]  

  • 47. Newborn screening for haemoglobinopathies: the Brussels experience.
    Gulbis B; Tshilolo L; Cotton F; Lin C; Vertongen F
    J Med Screen; 1999; 6(1):11-5. PubMed ID: 10321364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sickle cell disease: comprehensive screening and management in newborns and infants. Agency for Health Care Policy and Research.
    Clin Pract Guidel Quick Ref Guide Clin; 1993 Apr; (6):1-13. PubMed ID: 8485604
    [No Abstract]   [Full Text] [Related]  

  • 49. Chromatographic analysis of Hb S for the diagnosis of various sickle cell disorders in Pakistan.
    Hashmi NK; Moiz B; Nusrat M; Hashmi MR
    Ann Hematol; 2008 Aug; 87(8):639-45. PubMed ID: 18465131
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Haemoglobinopathies and newborn haemoglobinopathy screening in Germany.
    Dickerhoff R; Genzel-Boroviczeny O; Kohne E
    J Clin Pathol; 2009 Jan; 62(1):34. PubMed ID: 19103856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Prevalence of Sickle Cell Disease and Its Implication for Newborn Screening in Germany (Hamburg Metropolitan Area).
    Grosse R; Lukacs Z; Cobos PN; Oyen F; Ehmen C; Muntau B; Timmann C; Noack B
    Pediatr Blood Cancer; 2016 Jan; 63(1):168-70. PubMed ID: 26275168
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Sickle cell disease in heel injection screening. II].
    Vansenne F; de Borgie CA; Bouva MJ; Legdeur MA; van Zwieten R; Petrij F; Peters M
    Ned Tijdschr Geneeskd; 2009 May; 153(18):858-61. PubMed ID: 19475864
    [No Abstract]   [Full Text] [Related]  

  • 53. [Abnormal haemoglobins in the newborn human population of Costa Rica].
    Abarca G; Navarrete M; Trejos R; de Céspedes C; Saborío M
    Rev Biol Trop; 2008 Sep; 56(3):995-1001. PubMed ID: 19419022
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA testing for sickle cell anemia in Africa: Implementation choices for the Democratic Republic of Congo.
    Ngole M; Race V; Mbayabo G; Lumbala P; Songo C; Lukusa PT; Devriendt K; Matthijs G; Lumaka A
    J Clin Lab Anal; 2022 May; 36(5):e24398. PubMed ID: 35405024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study.
    Nnodu OE; Sopekan A; Nnebe-Agumadu U; Ohiaeri C; Adeniran A; Shedul G; Isa HA; Owolabi O; Chianumba RI; Tanko Y; Iyobosa JH; Adekile AD; Olopade OI; Piel FB
    Lancet Haematol; 2020 Jul; 7(7):e534-e540. PubMed ID: 32589979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Paper-Based Test for Screening Newborns for Sickle Cell Disease.
    Piety NZ; George A; Serrano S; Lanzi MR; Patel PR; Noli MP; Kahan S; Nirenberg D; Camanda JF; Airewele G; Shevkoplyas SS
    Sci Rep; 2017 Apr; 7():45488. PubMed ID: 28367971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Neonatal screening for hemoglobinopathies in the Brussels region].
    Tshilolo L; Gulbis B; Barlow P; Damis E; Denis-Song R; Ferster A; Haumont D; Vanderpas JB; Pardou A; Schwers J; Vokaer A; Vertongen F
    Rev Med Brux; 1997 Apr; 18(2):70-3. PubMed ID: 9221465
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The frequency of the sickle allele in Jamaica has not declined over the last 22 years.
    Hanchard NA; Hambleton I; Harding RM; McKenzie CA
    Br J Haematol; 2005 Sep; 130(6):939-42. PubMed ID: 16156863
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Campaign to control genetic blood diseases in Bahrain.
    Al Arrayed S
    Community Genet; 2005; 8(1):52-5. PubMed ID: 15767757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Sickle cell disease: exotic disease or a Belgian public health problem?].
    Gulbis B; Ferster A; Kentos A; N'Gay Munungi D; Cotton F; Rongé E; Dresse MF; Bradstreet C; Cochaux P; Vertongen F
    Rev Med Brux; 2005 Sep; 26(4):S309-13. PubMed ID: 16240879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.